Rafarma Adds Prestigious New Board Chairman Ilia Shpurov
September 18, 2020 09:32 ET
|
RAFARMA PHARMACEUTICALS INC
Ljubljana, Slovenia, Sept. 18, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce the appointment of Ilia Shpurov as Chairman of the Board. Mr. Shpurov has a...
Rafarma Conducts Strategy Conference in Thailand for University and Hospital Joint Venture
September 02, 2020 11:01 ET
|
RAFARMA PHARMACEUTICALS INC
Ljubljana, Slovenia, Sept. 02, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) reports that Mr. Anucha Pehtpeng, Rafarma’s Director of Thai Operations, represented the company...
Rafarma Establishes Thailand Corporate Entity For Merger and Expansion Projects
August 25, 2020 11:13 ET
|
RAFARMA PHARMACEUTICALS INC
Ljubljana, Slovenia, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. “OTC:(RAFA)” is pleased to announce that it has established a new corporate entity in Thailand. The entity is...
Rafarma - Biocogency Acquisition Progresses to Preparation of GAAP Financials and Form 10 Drafting for Full SEC Reporting
August 14, 2020 09:15 ET
|
RAFARMA PHARMACEUTICALS INC
Ljubljana, Slovenia, Aug. 14, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to update its shareholders on the progress of its acquisition by the R. & D. BIOCOGENCY...
Letter to Shareholders Regarding Rafarma Acquisition by R. & D. Biocogency Laboratories Inc.
August 05, 2020 09:15 ET
|
RAFARMA PHARMACEUTICALS INC
Ljubljana, Slovenia, Aug. 05, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) presents the following letter to Rafarma shareholders from CEO Vladimir Dolgolenko: To Our...
Rafarma to be Acquired by R. & D. Biocogency Laboratories Inc.
August 04, 2020 09:15 ET
|
RAFARMA PHARMACEUTICALS INC
Ljubljana, Slovenia, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce that it has reached an agreement to be acquired by R. & D. Biocogency...
Rafarma Inks Deal For CBD-Infused Drink Product
June 22, 2020 09:15 ET
|
RAFARMA PHARMACEUTICALS INC
Ljubljana, Slovenia, June 22, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce finalization of the agreement with Destination Marketing Group Co. Ltd....
Rafarma Finalizes Announces New Product
June 15, 2020 10:48 ET
|
RAFARMA PHARMACEUTICALS INC
Ljubljana, Slovenia, June 15, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, (OTC:(RAFA) Inc. is happy to announce commencement of tests for its new product “HempySleep”. The product was designed...
Rafarma Finalizes Acquisition of Laskavy Patents, Prepared as Global Markets Reset
April 16, 2020 12:51 ET
|
RAFARMA PHARMACEUTICALS INC
Ljubljana, Slovenia, April 16, 2020 (GLOBE NEWSWIRE) -- RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA)” - Rafarma Pharmaceuticals, Inc. is pleased to announce acquisition of all outstanding US and...
Rafarma Establishes Advisory Board, Appoints First Member and Will Acquire Additional Patents and Intellectual Property
April 06, 2020 12:15 ET
|
RAFARMA PHARMACEUTICALS INC
Ljubljana, Slovenia, April 06, 2020 (GLOBE NEWSWIRE) -- RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA)” - In establishing its Advisory Board, Rafarma Pharmaceuticals announces the appointment of its first...